drugset / Trial / NCT00740831
PGL4001 Versus GnRH-agonist in Uterine Myomas
RandomizedParallel-groupDouble-blindTreatment
Summary
This trial will assess the efficacy and safety of PGL4001 versus GnRH agonist, over a 3-month period for the pre-operative treatment of pre-menopausal women suffering from excessive uterine bleeding due to uterine myoma.
Timeline
- Start
- 2008-08
- Primary completion
- 2010-01
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Leuprolide | Other / unclassified | 3.75 mg | Intramuscular |
| Subject | Ulipristal Acetate | Unknown | 5 mg | Oral |
| Subject | Ulipristal Acetate | Unknown | 10 mg | Oral |